CRISPR-Mediated Genome Engineering for Protein Depletion

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15203415

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides compositions and methods for tagging a target gene with a degron (e.g., auxin-inducible degron) in a variety of eukaryotic cells using the CRISPR genome-editing technology. Also provided are cells that have been genetically modified using such compositions and methods.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE JOHNS HOPKINS UNIVERSITY3400 NORTH CHARLES STREET BALTIMORE MD 21218

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cheeseman, Iain Cambridge, US 3 47
Holland, Andrew Baltimore, US 11 302
McKinley, Kara Cambridge, US 1 46

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation